Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a bridge program close the health gap for people with serious mental illness?

NCT ID NCT06859060

Disease control Sponsor: Ponce Medical School Foundation, Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 25, 2026 · Last updated Aug 26, 2026 · Updated 1 time

Summary

This trial tests whether a culturally adapted program called BRIDGES can help Puerto Ricans with serious mental illness get better preventive care. Participants receive monthly sessions with healthcare managers who focus on care coordination and reducing stigma. The goal is to see if this approach improves access to services like check-ups and screenings, potentially reducing chronic disease disparities.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A culturally adapted behavioral intervention with monthly sessions led by healthcare managers to improve care coordination and reduce stigma.
What this could lead to
If effective, this program could reduce chronic disease disparities and improve preventive care access for people with serious mental illness in Puerto Rico.
What could go wrong
This is a behavioral intervention, so results may vary by participant engagement. The trial is not a drug study, and its success depends on consistent participation and healthcare system support.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 300 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2025

Expected to finish

Feb 2029

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

21 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria: Adults receiving psychiatric or psychological services at the Wellness Center or the Mayaguez Medical Center - Primary Care Diagnosed with at least one serious mental illness SMI (e.g., schizophrenia, bipolar disorder, major depression, etc.) Have at least one risk factor or a diagnosis of a chronic health condition (e.g., diabetes, overweight, hypertension, etc.). Be willing to receive or continue preventive medical care with a primary care physician. Exclusion criteria: Have started psychiatric or mental health services at least one month before Have been diagnosed with a general mental health condition (e.g., Depression or Anxiety).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic disease are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Chronic Disease psychiatric disorder Social Stigma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic disease Serious mental illness

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Mayagüez Medical Center Primary Care Psychology Clinic

    RECRUITING

    Mayagüez, Puerto Rico, 00681, Puerto Rico

  • PHSU Wellness Center

    RECRUITING

    Ponce, Puerto Rico, 00716, Puerto Rico

More trials for these conditions

Other studies related to the condition(s) this trial covers.